What Happened?
San Diego, CA-based VelosBio,-Inc. Appointed Dave Johnson as Chairman and Chief Executive Officer
About the Company
VelosBio Inc. is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer. Its lead candidate, VLS-101, is a ROR1-directed ADC being developed for patients with hematologic and solid tumor malignancies. The company is developing a broad pipeline of therapeutics targeting ROR1 in oncologic indications with high unmet medical need.
About the Person
Dave Johnson is Chairman and Chief Executive Officer at VelosBio, Inc.. Previously, Dave held various senior HR leadership roles in the industry.
Info Source
News
Short Profile